ArticleIDCases2026
Acute pancreatitis as a complication of epstein-barr virus infection: A case report and narrative review.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Epstein-Barr virus (EBV) infection is common, but EBV-associated acute pancreatitis is rare and heterogeneous. We describe an adult case and synthesize published cases to inform diagnosis and management. Case presentation: A 40-year-old man presented with sore throat and mild abdominal pain; examination showed a right peritonsillar abscess with uvular deviation. Laboratory testing revealed lipase 3704 U/L and elevated inflammatory markers; abdominal CT confirmed non-complicated acute pancreatitis. He received incision and drainage of the abscess plus conservative pancreatitis care. Symptoms resolved rapidly, lipase decreased to 352 U/L by day 2, and he was subsequently discharged. EBV serology later confirmed acute infection, and patient was asymptomatic at 2-month follow-up. Methods: We searched PubMed to August 24, 2025, using ("Epstein-Barr virus" OR "EBV") AND "pancreatitis," including human case reports or series of EBV-associated acute pancreatitis. There were no language restrictions. Results: Of 60 records, 13 cases met criteria. Eight involved adults and most patients were female. Abdominal pain was common, but classic mononucleosis symptoms were infrequently reported. CT was the predominant diagnostic modality. Management was conservative in nearly all reports and antivirals were rarely used. Outcomes were generally favorable, with one fatal case. Conclusions: EBV should be considered in unexplained acute pancreatitis, particularly when common etiologies are excluded or concurrent EBV features are present. Prognosis is typically good with supportive care, but coexisting risk factors may predispose patients to a more severe or complicated course. Transparent reporting of cofactors will clarify whether EBV acts as an opportunistic trigger or independent cause.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.